Barriers to effective TRAIL-targeted therapy of malignancy

被引:83
作者
Dyer, Martin J. S. [1 ]
MacFarlane, Marion [1 ]
Cohen, Gerald M. [1 ]
机构
[1] MRC, Toxicol Unit, Leicester, Leics, England
基金
英国医学研究理事会;
关键词
D O I
10.1200/JCO.2007.13.1011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:4505 / 4506
页数:3
相关论文
共 10 条
  • [1] On the TRAIL toward death receptor-based cancer therapeutics
    Gajewski, Thomas F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (11) : 1305 - 1307
  • [2] Histone deacetylase inhibitors potentiate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in lymphoid malignancies
    Inoue, S
    MacFarlane, M
    Harper, N
    Wheat, LMC
    Dyer, MJS
    Cohen, GM
    [J]. CELL DEATH AND DIFFERENTIATION, 2004, 11 (Suppl 2) : S193 - S206
  • [3] Inhibition of histone deacetylase class I but not class II is critical for the sensitization of leukemic cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis
    Inoue, Satoshi
    Mai, Antonello
    Dyer, Martin J. S.
    Cohen, Gerald M.
    [J]. CANCER RESEARCH, 2006, 66 (13) : 6785 - 6792
  • [4] KOSCHNY R, J MOL MED
  • [5] Bortezomib sensitizes primary human astrocytoma cells of WHO grades I to IV for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis
    Koschny, Ronald
    Holland, Heidrun
    Sykora, Jaromir
    Haas, Tobias L.
    Sprick, Martin R.
    Ganten, Tom M.
    Krupp, Wolfgang
    Bauer, Manfred
    Ahnert, Peter
    Meixensberger, Juergen
    Walczak, Henning
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (11) : 3403 - 3412
  • [6] TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies
    MacFarlane, M
    Kohlhaas, SL
    Sutcliffe, MJ
    Dyer, MJS
    Cohen, GM
    [J]. CANCER RESEARCH, 2005, 65 (24) : 11265 - 11270
  • [7] Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1
    MacFarlane, M
    Inoue, S
    Kohlhaas, SL
    Majid, A
    Harper, N
    Kennedy, DBJ
    Dyer, MJS
    Cohen, GM
    [J]. CELL DEATH AND DIFFERENTIATION, 2005, 12 (07) : 773 - 782
  • [8] Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia
    MacFarlane, M
    Harper, N
    Snowden, RT
    Dyer, MJS
    Barnett, GA
    Pringle, JH
    Cohen, GM
    [J]. ONCOGENE, 2002, 21 (44) : 6809 - 6818
  • [9] mTOR controls FLIPs translation and TRAIL sensitivity in glioblastoma multiforme cells
    Panner, A
    James, CD
    Berger, MS
    Pieper, RO
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (20) : 8809 - 8823
  • [10] Tolcher AW, 2007, J CLIN ONCOL, V25, P1390, DOI 10.1200/JCO.2006.08.8898